• Invest-NL's October 30, 2026, report projects around €17 billion in additional annual Dutch agrifood biotech revenue by 2040 with faster commercialization.
• Fermentation-based food ingredients could generate around €8 billion annually with policy changes, versus approximately €2 billion without them.
• European authorization for biological crop protection takes eight to ten years, prompting companies to launch first in Brazil and the US.
• New food ingredients face European authorization delays of one to three years versus the US, while first factories lack suitable financing.
• Factories cost tens or hundreds of millions of euros; public capital could share initial investment risks to attract private financing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invest-NL NV published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.